Results 51 to 60 of about 61,607 (214)

Allogeneic hematopoietic stem cell transplantation in mycosis fungoides [PDF]

Anais Brasileiros de Dermatologia, 2013
Mycosis Fungoides is typically an indolent disease in early stages. However, approximately 30% of patients have advanced staged disease at presentation and 20% will develop it at some time. These patients have a poorer prognosis with a median survival of
Angelo Atalla, Abrahão Elias Hallack Neto, Denise Bittencourt Siqueira, Gabriela Cumani Toledo   +3 more
doaj   +1 more source

Plasticity after allogeneic hematopoietic stem cell transplantation [PDF]

bchm, 2008
Abstract The postulated almost unlimited potential of transplanted hematopoietic stem cells (HSCs) to transdifferentiate into cell types that do not belong to the hematopoietic system denotes a complete paradigm shift of the hierarchical hemopoietic tree.
Rovó, A., Gratwohl, A.
openaire   +4 more sources

Nutritional status of patients submitted to transplantation of allogeneic hematopoietic stem cells: a retrospective study

Revista Brasileira de Hematologia e Hemoterapia, 2014
Objective:This study aimed to describe and compare the nutritional status of adult patients submitted to allogeneic hematopoietic stem cell transplantation at two different time points (admission and discharge).Methods:A retrospective, descriptive and ...
Érika Elias Ferreira, Daiane Cristina Guerra, Kátia Baluz, Wander de Resende Furtado, Luis Fernando da Silva Bouzas   +4 more
doaj   +1 more source

Allogeneic hematopoietic stem cell transplantation for myelofibrosis

Haematologica, 2008
Primary myelofibrosis (PMF) or myelofibrosis secondary to polycythemia vera (PV-MF) or essential thrombocythemia (ET-MF) can be cured only by means of allogeneic hematopoietic stem cell transplantation (HSCT).[1][1] However, the age of the patient, the number of circulating blasts ...
openaire   +3 more sources

High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution

, 2002
Nonmyeloablative conditioning is increasingly used for transplantation in a wide range of diseases, but little is known about its impact on the incidence of infections and immune reconstitution.
Mahendra, P, Marshall, T, O'Gorman, P, Osman, H., Chakraverty, R, Hale, G., Osman, H, Peggs, K., O'Gorman, P., Mahendra, Premini, Mackinnon, S, Fegan, Christopher, Chopra, Ravinder, Linch, DC, Goldstone, A.H., Chopra, R, Waldmann, H., Milligan, D.W., Chakrabarti, Suparno, Hale, G, Chakrabarti, S., Marshall, T., Chakrabarti, S, Peggs, K, Chakraverty, Ronjon, Chopra, R., Waldmann, H, Kottaridis, P.D., Craddock, C., Milligan, DW, Mackinnon, S., Chakraverty, R., Kottaridis, PD, Yong, K., Kottaridis, P, Milligan, Donald, Mahendra, P., Craddock, Charles; id_orcid, Craddock, C, Yong, K, Goldstone, AH, Waldmann, Herman, Fegan, CD, Fegan, C.D., Linch, D.C.   +44 more
core   +1 more source

A survey on cellular and engineered tissue therapies in Europe in 2008 [PDF]

, 2010
Cellular therapy is an evolving investigational treatment modality in regenerative medicine, but little published information is available on its current use.
Martin, Ivan, Niederwieser, Dietger, Gratwohl, Alois, Baldomero, Helen, Tyndall, Alan   +4 more
core   +1 more source

Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells : implications for adoptive immunotherapy after allogeneic stem cell transplantation

, 2010
Background: Rhabdomyosarcoma is the most common soft tissue sarcoma in childhood and has a poor prognosis. Here we assessed the capability of ex vivo expanded cytokine-induced killer cells to lyse both alveolar and embryonic rhabdomyosarcoma cell lines ...
H. Kreyenberg, Gerrit Weber, S. Kloss, Bader, Peter, Koscielniak, Ewa, A. Willasch, Selim Kuci, T. Klingebiel, E. Koscielniak, Laer, Dorothee von, Miriam Stais, Willasch, Andre Manfred, D. von Laer, Klingebiel, Thomas, Klöß, Stephan, Stais, Miriam, Kuçi, Selim, Peter Bader, Eva Rettinger, Thomas Klingebiel, B. Voss, Z. Kuci, Kreyenberg, Hermann, Stephan Klöss, G. Weber, Dorothee Von Laer, E. Rettinger, Zyrafete Kuci, Kuçi, Zyrafete, Rettinger, Eva, Bernhard Voss, M. Stais, P. Bader, Hermann Kreyenberg, Weber, Gerrit, Voß, Bernhard, Ewa Koscielniak, Andre Willasch, S. Kuci   +38 more
core   +1 more source

A Comparison of Allogeneic and Autologous Hematopoietic Stem Cell Transplantation for Acute Myeloblastic Leukemia [PDF]

International Journal of Hematology-Oncology and Stem Cell Research, 2009
Introduction: Acute Myelogenous Leukemia (AML) is a clonal  malignant disease of hematopoietic tissue. The early use of  Hematopoietic Stem Cell Transplantation (HSCT) for AML was for patients with advanced stages of disease, usually while in relapse, in
Ardeshir Ghavamzadeh, Atefeh Masnavi, Farnaz Khatami, Arash Jalali, Kamran Alimoghaddam   +4 more
doaj   +1 more source

Hematopoietic stem cell transplantation in Iran: 1991 to 2008

Hematology/Oncology and Stem Cell Therapy, 2008
Since 1991,2042 first hematopoietic stem cell transplants (HSCT) have been performed at the Hematology- Oncology and stem cell Transplantation Research center at Tehran university of Medical sciences.
Ardeshir Ghavamzadeh, Kamran Alimogaddam, Mohammad Jahani, Seyedasadollah Mousavi, Masoud Iravani, Babak Bahar, Ali Khodabandeh, Farnaz Khatami, Arash Jalali   +8 more
doaj   +1 more source

The Role of Fecal Microbiota Transplantation in the Allogeneic Stem Cell Transplant Setting

Microorganisms, 2023
Microbiota changes during allogeneic hematopoietic stem cell transplantation has several known causes: conditioning chemotherapy and radiation, broad-spectrum antibiotic administration, modification in nutrition status and diet, and graft-versus-host ...
Elisabetta Metafuni, Luca Di Marino, Sabrina Giammarco, Silvia Bellesi, Maria Assunta Limongiello, Federica Sorà, Filippo Frioni, Roberto Maggi, Patrizia Chiusolo, Simona Sica   +9 more
doaj   +1 more source